Indegene Limited has submitted a regulatory disclosure to BSE Limited and National Stock Exchange of India Limited regarding a scheduled investor/analyst meeting. The disclosure is made pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company officials will meet with representatives of Mirabilis Investment Trust on Friday, 13 November 2026. The meeting will be conducted as a 1x1 meeting in person at Bengaluru, Karnataka, India.
The company explicitly states that no unpublished price sensitive information will be shared during this investor/analyst meeting. The schedule is noted to be subject to changes, if any.
This information will be made available on the company's website at https://www.indegene.com/.
The disclosure is signed by Srishti Ramesh Kaushik, who holds the position of Company Secretary and Compliance Officer at Indegene Limited. The digital signature timestamp shows the document was signed on 06 November 2026 at 13:58:57 +05:30.
Company contact information provided includes: Third Floor, Aspen G-4 Block, Manyata Embassy Business Park (SEZ), Outer Ring Road, Nagawara, Bengaluru-560 045, Karnataka, India. Phone: +91 80 4674 4567, +91 80 4644 7777. Email: compliance.officer@indegene.com. Website: www.indegene.com. CIN: L73100KA1998PLC102040.